FDA delays Leqembi decision; Artiva raises $300M; Pharvaris prices offering

May 8, 2026 11:09 AM EDT News Briefing FDA de­lays Leqem­bi de­ci­sion; Arti­va rais­es $300M on RA da­ta; Phar­varis prices of­fer­ing ENDPOINTS 🗓️ FDA de­lays sub­cu­ta­neous Leqem­bi de­ci­sion: Orig­i­nal­ly slat­ed for lat­er this month, the de­ci­sion date now falls on Au­gust 24, Bio­gen and Ei­sai Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER